Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression

Antimicrob Agents Chemother. 2013 Jul;57(7):3240-9. doi: 10.1128/AAC.00279-13. Epub 2013 Apr 29.


Vancomycin-intermediate Staphylococcus aureus (VISA) strains often arise by mutations in the essential two-component regulator walKR; however their impact on walKR function has not been definitively established. Here, we investigated 10 MRSA strains recovered serially after exposure of vancomycin-susceptible S. aureus (VSSA) JKD6009 to simulated human vancomycin dosing regimens (500 mg to 4,000 mg every 12 h) using a 10-day hollow fiber infection model. After continued exposure to the vancomycin regimens, two isolates displayed reduced susceptibility to both vancomycin and daptomycin, developing independent IS256 insertions in the walKR 5' untranslated region (5' UTR). Quantitative reverse transcription-PCR (RT-PCR) revealed a 50% reduction in walKR gene expression in the IS256 mutants compared to the VSSA parent. Green fluorescent protein (GFP) reporter analysis, promoter mapping, and site-directed mutagenesis confirmed these findings and showed that the IS256 insertions had replaced two SigA-like walKR promoters with weaker, hybrid promoters. Removal of IS256 reverted the phenotype to VSSA, showing that reduced expression of WalKR did induce the VISA phenotype. Analysis of selected WalKR-regulated autolysins revealed upregulation of ssaA but no change in expression of sak and sceD in both IS256 mutants. Whole-genome sequencing of the two mutants revealed an additional IS256 insertion within agrC for one mutant, and we confirmed that this mutation abolished agr function. These data provide the first substantial analysis of walKR promoter function and show that prolonged vancomycin exposure can result in VISA through an IS256-mediated reduction in walKR expression; however, the mechanisms by which this occurs remain to be determined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Base Sequence
  • DNA Transposable Elements*
  • DNA, Bacterial / genetics
  • Daptomycin / pharmacology
  • Gene Expression Regulation, Bacterial
  • Genome, Bacterial
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Mutagenesis, Insertional
  • Mutagenesis, Site-Directed
  • Peptidoglycan Glycosyltransferase / genetics
  • Promoter Regions, Genetic / genetics
  • Protein Kinases / genetics
  • Sequence Analysis, DNA
  • Vancomycin / pharmacology*
  • Vancomycin Resistance / genetics*


  • Anti-Bacterial Agents
  • Bacterial Proteins
  • DNA Transposable Elements
  • DNA, Bacterial
  • Vancomycin
  • Peptidoglycan Glycosyltransferase
  • SceD protein, Staphylococcus aureus
  • Protein Kinases
  • AgrC protein, Staphylococcus
  • Daptomycin